The global endobronchial ultrasound (EBUS) biopsy market is on a trajectory of consistent growth, driven by a growing preference for minimally invasive diagnostic procedures, increasing incidence of lung cancer, and advancements in imaging and bronchoscopy technology. Valued at USD 733.19 million in 2024, the market is projected to expand at a compound annual growth rate (CAGR) of...